Joint with: Proximity Based Biology and Therapeutics
The Ubiquitin Family in Biology and Disease

February 23-26, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Michael Rape, Christopher D. Lima and Bekky Feltham

  In Person
  On Demand

February 23-26, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Michael Rape, Christopher D. Lima and Bekky Feltham

Available Formats:   = In Person     = On Demand
Nicolas H. Thomä †, EPFL Lausanne
Ubiquitin Signaling in Transcription and DNA Repair
David P. Bartel †, Massachusetts Institute of Technology and Whitehead Institute
Ubiquitin and RNA Degradation
Brenda A. Schulman †, Max Planck Institute of Biochemistry
Molecular Machines of Ubiquitylation
Michele Pagano †, New York University School of Medicine
Networks of Ubiquitin-Dependent Signaling
Short Talk(s) Chosen from Abstracts
Christopher D. Lima, Memorial Sloan Kettering Cancer Center
SUMOylation Mechanisms
Yifat Merbl †, Weizmann Institute of Science
SUMO in the Immune Response
Allison Berger †, Takeda Development Center Americas, Inc.
Small Molecule SUMO Inhibition
Short Talk(s) Chosen from Abstracts
Sonya Neal †, University of California, San Diego
ER-Associated Quality Control
Susan Shao †, Harvard Medical School
Ribosome-Associated Quality Control
Michael Rape, University of California, Berkeley
Stress Response Silencing
David Komander †, Walter and Eliza Hall Institute of Medical Research
Ubiquitin and Parkinson’s Disease
Short Talk(s) Chosen from Abstracts
Yogesh Kulathu †, University of Dundee
UFM1 in Ribosome Control
F. Ulrich Hartl †, Max Planck Institute of Biochemistry
URM1 in Stress Signaling
Heran Darwin †, New York University School of Medicine
Pupylation
Short Talk(s) Chosen from Abstracts
Gwenn Hansen †, Nurix Therapeutics
Learnings from BTK Degrader Trials in Brain
Benjamin L. Ebert †, Dana-Farber Cancer Institute
Cereblon Targeting in Disease
Ingrid E. Wertz †, Lyterian Therapeutics
Death Inducing Peptides
Cristina Mayor-Ruiz †, IRB Barcelona
CRL Signaling and its use for Therapeutic Development
Short Talk(s) Chosen from Abstracts
Kevin D. Corbett †, University of California, San Diego
Bacterial E1-E2 Fusions
Ivan Dikic †, Goethe University Medical School
Non-Conventional Ubiquitylation
Bekky Feltham, Walter and Eliza Hall Institute of Medical Research
Ubiquitin Biology in Inflammation
Short Talk(s) Chosen from Abstracts
Monday, February 23, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, February 24, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Ubiquitin System – A Global View
9:00–11:15 AM
Coffee Break
9:30–9:50 AM
On Own for Lunch
11:15–5:00 PM
Poster Setup
11:15–1:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
SUMO: The First Ubiquitin-Like Molecule
5:00–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, February 25, 2026
Breakfast
7:00–8:00 AM
Quality Control Ubiquitylation in Development and Disease
8:00–11:00 AM
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Panel Discussion: Meet the Editors
1:45–2:45 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
New Insights into Ubiquitin-Like Proteins
5:00–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, February 26, 2026
Breakfast
7:00–8:00 AM
Learning from the Clinic
8:00–11:00 AM
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2
2:30–4:30 PM
Coffee Available
4:30–5:00 PM
Ubiquitin at the Crossroads of Infection and Immunology
5:00–6:45 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, February 27, 2026
Departure
12:00–11:59 PM

Subscribe for Updates